This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Mad in America has previously examined the problems with conflicts of interest in research but this time we extend that to look at the potential effect of COIs on diagnostic tools such as the Diagnostic and Statistical Manual of Mental Disorders (DSM). Cosgrove: Definitely. He was also a major user for an extended period.
You’re also an author, and you’ve written on topics such as aging, genetics, mental representation, biological functions, mechanisms in science, and the concept of information in neuroscience. So why do we call schizophrenia a mental disorder, but not believing in conspiracy theories?
Dr. Moncrieff is a psychiatrist who works in the National Health Service in the United Kingdom. Moncrieff: When I was in medical school we were taught, as we’re still officially taught now, the biopsychosocial model of mental disorders. Whitaker: So now you go out and you’re in the asylum or mental hospital.
R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. This applies in the mental illness world and everywhere in medicine.
Within this, some parts of the neurodiversity movement take an uncritical or neutral perspective on the validity of psychiatric diagnoses such as—but not limited to—ASD and ADHD, backed up by unsubstantiated claims about biological and genetic causal factors. This heterogeneity makes it difficult to generalise.
Moore: We’re here to talk about some of your experiences of the mentalhealth system and polypharmacy, experiences which are beautifully captured in your book, May Cause Side Effects , published by Central Recovery Press in 2022. Thank you so much for joining me today for the Mad In America podcast. Everything is so reactive.
His work spans everything from the cultural history of mental illness to mindfulness, death anxiety, and resiliencenot the hollow kind that comes from pretending everythings fine, but the kind that comes from staring into the void and refusing to flinch. On a personal note, Brent has played a foundational role in my own journey.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content